These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 2690609)
21. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE? Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603 [TBL] [Abstract][Full Text] [Related]
22. [Resistance to ACE inhibitors. Myth or reality?]. Aumont MC; Juliard JM Arch Mal Coeur Vaiss; 2001 Sep; 94(9):1008-12. PubMed ID: 11603063 [TBL] [Abstract][Full Text] [Related]
23. Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor. Hasler C; Nussberger J; Maillard M; Forclaz A; Brunner HR; Burnier M Clin Pharmacol Ther; 2005 Nov; 78(5):501-7. PubMed ID: 16321616 [TBL] [Abstract][Full Text] [Related]
24. The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system. Humke U; Levens N; Wood J; Hofbauer K J Pharmacol Exp Ther; 1992 Jan; 260(1):29-35. PubMed ID: 1309874 [TBL] [Abstract][Full Text] [Related]
25. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade? Gerc V; Buksa M; Loza V; Kulic M Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117 [TBL] [Abstract][Full Text] [Related]
26. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects. Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782 [TBL] [Abstract][Full Text] [Related]
27. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study. Lee AF; MacFadyen RJ; Struthers AD Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954 [TBL] [Abstract][Full Text] [Related]
28. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218 [TBL] [Abstract][Full Text] [Related]
29. [What have we learned from converting enzyme inhibitors on renin-angiotensin system?]. Waeber B; Nussberger J; Brunner HR Rev Prat; 1992 Dec; 42(20):2529-32. PubMed ID: 1338608 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic potential of renin inhibitors in the management of cardiovascular disorders. Stanton A Am J Cardiovasc Drugs; 2003; 3(6):389-94. PubMed ID: 14728059 [TBL] [Abstract][Full Text] [Related]
31. Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans. Aldigier JC; Huang H; Dalmay F; Lartigue M; Baussant T; Chassain AP; Leroux-Robert C; Galen FX J Cardiovasc Pharmacol; 1993 Feb; 21(2):289-95. PubMed ID: 7679164 [TBL] [Abstract][Full Text] [Related]
32. Recent changes in the landscape of combination RAS blockade. Epstein BJ; Smith SM; Choksi R Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020 [TBL] [Abstract][Full Text] [Related]
34. Feedback analysis of the behavior of the renin-angiotensin system under inhibition of angiotensin-converting enzyme. Wada T; Aoyagi T; Iinuma H; Ogawa K; Kojima F; Nagai M; Kuroda H; Obayashi A; Takeuchi T Biotechnol Appl Biochem; 1988 Oct; 10(5):435-46. PubMed ID: 3058152 [TBL] [Abstract][Full Text] [Related]
35. Angiotensin converting enzyme inhibitors reduce alcohol consumption: some possible mechanisms and important conditions for its therapeutic use. Lingham T; Perlanski E; Grupp LA Alcohol Clin Exp Res; 1990 Feb; 14(1):92-9. PubMed ID: 2178480 [TBL] [Abstract][Full Text] [Related]
37. Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions. Tsikouris JP; Cox CD Pharmacotherapy; 2003 Sep; 23(9):1141-52. PubMed ID: 14524646 [TBL] [Abstract][Full Text] [Related]
38. [Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension]. Khadartsev AA; Logatkina AV; Terekhov IV; Bondar SS; Bondar NV Ter Arkh; 2017; 89(12):97-102. PubMed ID: 29411767 [TBL] [Abstract][Full Text] [Related]